Our first adult patient has received transfusion of blood plasma from a donor who has recovered from coronavirus (COVID-19), as part of a clinical trial looking at potential treatments for the virus.
Read more
MFT has continued its contribution to the global fight against Coronavirus by enrolling patients in a ground-breaking new study of the virus.
Read more
Our first patient has taken part in an interventional research trial testing potential treatments for people with severe COVID-19 infection, being cared for in an Intensive Care Unit.
Read more
Staff at MFT, already caring for patients on the frontline, are now helping fight the battle against COVID-19 by taking part in research
Read more
Our first patient has taken part in a research trial testing whether SNG001 – a drug treatment administered via a nebuliser – could be a potential treatment for COVID-19 (coronavirus).
Read more
MFT has recruited more than 400 patients to research trials in an attempt to better understand and treat COVID-19.
Read more
The first MFT patient has taken part in a research trial which is testing potential treatments for COVID-19 (coronavirus).
Read more
Researchers at Manchester University NHS Foundation Trust (MFT) will benefit from a £5 million European research award to fight malignant pleural mesothelioma (MPM).
Read more
